Hello there! It’s Barrie Einarson from Trade Ideas, back with another edition of our popular series, ‘What Makes This Trade Great’. Today, we’ll delve into an intriguing situation involving two stocks – EWTX and CYTK, shedding light on why EWTX has seen substantial movement, and the connection with CYTK. Understanding these scenarios can deliver an enriching experience to both expert and newbie traders, so let’s get started! To Subscribe: https://go.trade-ideas.com/SHQ
Use Promo Code BARRIE25 for 25% off

The AI Prediction

Before we dive into the details, it’s important to note that we’ve had EWTX in our AI-based recommendation system. Initially recommended when it was trading at 11.11, it’s grown substantially and is presently at 11.70. Now, the million-dollar question – why such a significant movement?

The Full Story

To understand this intriguing surge in EWTX shares, we have to take a detour to another stock – CYTK. Sounds confusing? Hang in there, it will all make sense soon.

Last week, CYTK experienced a dramatic rise in share price. It surged from approximately 34 to 40 – a remarkable increase. This massive increase was driven by some positive news regarding their phase three drug trials.

The drug, currently at phase three, reported hugely positive results, bringing about a significant market reaction.

As a result of this good news, the share price almost doubled – from 40 to nearly 80 overnight!

The EWTX ÷ CYTK Connection

So, what’s the connection between EWTX and CYTK? Here’s the deal: EWTX is expected to be a ‘sympathy play’. Essentially, sympathy play refers to a scenario where the price movement in one security leads to an impact on another security, even if the latter doesn’t have any fresh news. In EWTX’s case, they are believed to be developing a similar drug as CYTK.

Although they are still in the early stages, potentially at phase one, the market seems to have vectored in CYTK’s success and its implications for EWTX.

The point of a ‘sympathy play’ is that EWTX might encounter similar success to CYTK due to the similarities in their drug development processes.

This conjecture is driving EWTX’s shares. Note that there’s no certainty that EWTX will indeed be successful with its drug. However, such anticipatory movements are part and parcel of trading, as markets often move on expectations and informed guesses.

This was a rewarding alert for our AI system to catch at their initial price. We will continue to watch its path; it’s too early to predict where it might stall. A closer look at the monthly chart and next highs will give further insights.

We don’t know yet if EWTX will follow CYTK’s trajectory. However, exploring these possibilities presents us with a fascinating insight into the dynamic world of trading.

Alright, folks, that’s it for now. It was great bringing you another exciting episode of ‘What Makes This Trade Great’. We’ll continue to follow EWTX (and CYTK) and will keep you updated with significant developments. See you tomorrow with yet another interesting case study.

Happy trading!